Registration

SEQIRUS for SEQIRUS

Firm
Client
Income
—
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

The Pandemic and All Hazards Preparedness Act reauthorization Federal appropriations for biodefense and biopreparedness Regulatory issues related to biodefense and influenza biopreparedness

LobbyistCovered position, as disclosed
PHYLLIS FROSST New —

Medical/Disease Research/Clinical Labs MED

The Pandemic and All Hazards Preparedness Act reauthorization Federal appropriations for biodefense and biopreparedness Regulatory issues related to biodefense and influenza biopreparedness

LobbyistCovered position, as disclosed
PHYLLIS FROSST New —

Science/Technology SCI

The Pandemic and All Hazards Preparedness Act reauthorization Federal appropriations for biodefense and biopreparedness Regulatory issues related to biodefense and influenza biopreparedness

LobbyistCovered position, as disclosed
PHYLLIS FROSST New —

Manufacturing MAN

The Pandemic and All Hazards Preparedness Act reauthorization Federal appropriations for biodefense and biopreparedness Regulatory issues related to biodefense and influenza biopreparedness

LobbyistCovered position, as disclosed
PHYLLIS FROSST New —

Disaster Planning/Emergencies DIS

The Pandemic and All Hazards Preparedness Act reauthorization Federal appropriations for biodefense and biopreparedness Regulatory issues related to biodefense and influenza biopreparedness

LobbyistCovered position, as disclosed
PHYLLIS FROSST New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
CSL LIMITED Australia Australia 100.0% $538,000

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.